Trials / Completed
CompletedNCT06046261
Exploring the Impact of " ACP Board Game for Life" on Death Preparation and Anxiety in Patients With Stage 4 and 5 Chronic Kidney Diseases: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- National Cheng-Kung University Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
This study was to explore the impacts of participating in "ACP board game for life" on death preparation, death anxiety, end-of-life care preferences, and intervention perception in stage 4-5 CKD patients with advanced chronic kidney diseases in a medical center.
Detailed description
This study was to explore the impacts of participating in "ACP board game for life" on death preparation, death anxiety, end-of-life care preferences, and intervention perception in stage 4-5 CKD patients with advanced chronic kidney diseases in a medical center. A nonrandomized two-arm pretest and posttest quasi-experimental design was used. Patients in the control group received routine care while patients in the experimental group received routine care and ACP board game for life. The ACP board game, death preparation subscale, Chinese Likert death anxiety scale, self-created questionnaires and brief interview were used for data collection.
Conditions
- Chronic Kidney Disease
- Chronic Renal Failure
- Chronic Renal Insufficiency
- End of Life Care
- Advance Care Planning
- Death Anxiety
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ACP board game for life | The research subjects will be assigned to the experimental group or the control group according to their wishes. Those who are willing to participate the ACP board game will be assigned to the experimental group. The intervention time for each board game is around 2 hours. There are 60 cards in this ACP board game; the focus of the game is to know the participants' thoughts on the card options. Questionnaires need to be filled in before and after intervention. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-02-28
- Completion
- 2023-02-28
- First posted
- 2023-09-21
- Last updated
- 2023-09-25
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06046261. Inclusion in this directory is not an endorsement.